Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 19 GBX -1.3% Market Closed
Market Cap: 78.3m GBX
Have any thoughts about
Creo Medical Group PLC?
Write Note

Wall Street
Price Targets

CREO Price Targets Summary
Creo Medical Group PLC

Wall Street analysts forecast CREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CREO is 58.65 GBX with a low forecast of 45.45 GBX and a high forecast of 73.5 GBX.

Lowest
Price Target
45.45 GBX
139% Upside
Average
Price Target
58.65 GBX
209% Upside
Highest
Price Target
73.5 GBX
287% Upside
Creo Medical Group PLC Competitors:
Price Targets
MLSS
Milestone Scientific Inc
155% Upside
MDT
Medtronic PLC
19% Upside
SEDANA
Sedana Medical AB (publ)
23% Upside
7575
Japan Lifeline Co Ltd
3% Upside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
40% Upside
300326
Shanghai Kinetic Medical Co Ltd
32% Downside
ZIMV
ZimVie Inc
44% Upside
214150
Classys Inc
29% Upside

Revenue
Forecast

Revenue Estimate
Creo Medical Group PLC

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 4 years is -10%.

N/A
Past Growth
-10%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Creo Medical Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
Creo Medical Group PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CREO's stock price target?
Price Target
58.65 GBX

According to Wall Street analysts, the average 1-year price target for CREO is 58.65 GBX with a low forecast of 45.45 GBX and a high forecast of 73.5 GBX.

What is Creo Medical Group PLC's Revenue forecast?
Projected CAGR
-10%

The compound annual growth rate of Creo Medical Group PLC's revenue for the next 4 years is -10%.

Back to Top